Relationship will create new solutions for the early diagnosis
and detection of cancer and other diseases.
DANA
POINT, Calif., Sept. 13,
2024 /PRNewswire-PRWeb/ -- SecondOpinionExpert, Inc.
(SOE), a leading healthcare technology company, announced today
that it has entered into a strategic relationship agreement with
Base Molecular Resonance™ Technologies, LLC (BMRT) to advance
BMRT's patented technology in the healthcare space for the early
diagnosis and detection of cancer and other diseases.
We are honored to work with SOE, leveraging
their extensive expertise in the healthcare industry and their
robust capabilities as we deploy our revolutionary technology in
the medical sector, stated Bo Short,
Co-Founder and CEO of BMRT.
BMRT has constructed a device and established a new technology
called Base Molecular Resonance™ (BMR™). BMR™ represents a new area
of science regarding the nuclear resonance of all matter. This
patented technology can detect any compound or biological
substance, including every element on the periodic table, and up to
200 cancers and other diseases.
In a recent groundbreaking landmark study, BMR™ technology
demonstrated the ability to detect various cancers with 100%
accuracy in both blind and double-blind tests, yielding no false
positives or false negatives. This pivotal third-party study
positions Base Molecular Resonance™ Technologies at the forefront
of Quantum Physics applications, offering a transformative solution
that is set to redefine global standards in healthcare.
The BMRT device can detect cancerous cells through a simple,
harmless, non-invasive scan, providing instantaneous results. Early
detection has the potential to nearly eradicate late-stage cancer.
Ten million people die every year around the world from cancer;
600,000 in the United States
alone. It is anticipated that from 2023 to 2040 the incidence of
cancer will increase 63% and mortality by 74%. Currently, 40%-50%
of all cancers are detected between Stages 2-4. Late-stage
diagnosis means increased mortality, decreased access to care and
increases in costs to the patient, medical provider and the
insurance company.
BMR™ utilizes a proprietary frequency-identification protocol
for determining the specific frequency signatures of biological
agents, like cancer. The system transmits a frequency that matches
the resonance frequency of a target substance, inducing a resonant
response in the material. This response is then detected by the
receiver, which processes the signal to indicate the presence and
location of the target.
SOE will assist BMRT to advance the use of its technology and
device in the healthcare space. Additionally, SOE will consult with
BMRT on business and marketing strategy, will assist in procuring
grants and provide business development and other services to help
roll out BMRT's innovative solution to the medical segment. SOE
will also leverage its panel of 400+ board-certified medical
specialists, its extensive industry contacts, its technical
expertise and its other capabilities to assist BMRT with the
productization and roll out of BMRT's patented technology
"We are honored to work with SOE, leveraging their extensive
expertise in the healthcare industry and their robust capabilities
as we deploy our revolutionary technology in the medical sector,"
stated Bo Short, Co-Founder and CEO
of BMRT. "We have a unique opportunity to establish our solution as
the new standard for early cancer detection. Together, we have the
potential to save millions of lives, billions of dollars, and
alleviate immeasurable pain and suffering," Short added.
"SOE is pleased to be working with BMRT to leverage their game
changing technology to detect cancer and other diseases earlier and
more cost effectively" says Steve
Krause, President, SecondOpinionExpert, Inc. "This strategic
relationship with BMRT aligns perfectly with our mission of
providing innovative medical technology solutions that dramatically
improve patient outcomes while significantly reducing healthcare
delivery costs. We couldn't be more excited about helping BMRT to
revolutionize cancer detection and save lives," said Krause.
About SecondOpinionExpert
SOE's mission is to provide innovative medical technology
solutions to improve healthcare while reducing costs. We empower
patients, providers and payors to work together to make the best
possible medical decisions. SOE has three tech-enabled solution
platforms – Expert Opinions, Point-of-Care Facilities, and
Point-of-Care Mobile & Remote Services – all providing medical
expertise and targeted solutions.
Our patented system for medical opinions is built with both the
patient and their physicians in mind, improving diagnosis and
treatment planning, and enhancing patient trust and satisfaction
with the payor as well. SOE's panel of 400+ board-certified medical
specialists are available to render expert opinions informed as
needed by Artificial Intelligence (AI) and genomics. SOE also owns
and/or manages a rapidly growing network of facilities for
post-acute care and substance treatment. Our proprietary platform
for Electronic Medical Records (EMR) empowers best practices in
administration and medical services.
We provide targeted services for patient groups within a plan
who are the most difficult and costly to care for. Our proprietary
TeleMedics Mobile Platform empowers and chronicles on-site visits
from qualified medics or nurses. Mobile staff provide the human
connection, capturing vitals and doing diagnostics and
therapeutics, with the patient's doctor participating as needed
through live video. We provide Remote Patient Monitoring (RPM)
delivered through a strategic relationship with KangarooHealth,
inhome respirators delivered and monitored by SOE affiliate
Momentum Equipment and Pandemic Response through our MaxVax
solution.
Additional information can be found at SOE.care
About Base Molecular Resonance™ Technologies (BMRT)
BMRT has discovered a new area of Quantum Physics that utilizes
resonant frequencies to detect particle interactions at subatomic
levels. This technology, called Base Molecular Resonance™ (BMR™),
can detect any compound or biological substance, including every
element on the periodic table, and up to 200 cancers and other
diseases. With over 20 years of prototyping and testing proving its
unmatched detection capabilities, BMR™ has the potential to save
millions of lives by pinpointing weapons, explosives, and other
physical threats both up close and at great distances, and
detecting cancers and other diseases long before they present
clinical symptoms. The non-invasive, harmless, and instant scan has
broad implications in cancer diagnostics, public safety, law
enforcement, security, and military services.
For more information about BMRT and its groundbreaking
technology, visit www.BMRT.io
Media Contact
Jay Kilberg, SecondOpinionExpert,
Inc, 1 917.543.6285, jay.kilberg@soe.care, https://soe.care
Facebook, LinkedIn
View original content to download
multimedia:https://www.prweb.com/releases/second-opinion-expert-announces-strategic-relationship-agreement-with-base-molecular-resonance-technologies-302245370.html
SOURCE SecondOpinionExpert, Inc
